12-118066652-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019086.6(VSIG10):āc.1610A>Gā(p.Asp537Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000521 in 1,613,312 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_019086.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VSIG10 | NM_019086.6 | c.1610A>G | p.Asp537Gly | missense_variant | 9/9 | ENST00000359236.10 | |
LOC124903030 | XR_007063479.1 | n.221+4972T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VSIG10 | ENST00000359236.10 | c.1610A>G | p.Asp537Gly | missense_variant | 9/9 | 1 | NM_019086.6 | P1 | |
ENST00000617135.1 | n.255T>C | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 151982Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000363 AC: 90AN: 247754Hom.: 1 AF XY: 0.000342 AC XY: 46AN XY: 134566
GnomAD4 exome AF: 0.000550 AC: 803AN: 1461212Hom.: 1 Cov.: 30 AF XY: 0.000534 AC XY: 388AN XY: 726834
GnomAD4 genome AF: 0.000250 AC: 38AN: 152100Hom.: 0 Cov.: 31 AF XY: 0.000229 AC XY: 17AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.1610A>G (p.D537G) alteration is located in exon 9 (coding exon 9) of the VSIG10 gene. This alteration results from a A to G substitution at nucleotide position 1610, causing the aspartic acid (D) at amino acid position 537 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at